This topic contains a solution. Click here to go to the answer

Author Question: The experiment-wide error rate will be higher than the 0.05 significance level if the multiple ... (Read 80 times)

Alygatorr01285

  • Hero Member
  • *****
  • Posts: 564
The experiment-wide error rate will be higher than the 0.05 significance level if the multiple comparison tests for the mean difference between any two populations use the 0.05 level.
 
  Indicate whether the statement is true or false

Question 2

Of the two types of statistical errors, the one that decision makers have most control over is Type I error.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

yeungji

  • Sr. Member
  • ****
  • Posts: 319
Answer to Question 1

TRUE

Answer to Question 2

TRUE




Alygatorr01285

  • Member
  • Posts: 564
Reply 2 on: Jun 24, 2018
Great answer, keep it coming :)


laurnthompson

  • Member
  • Posts: 334
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The liver is the only organ that has the ability to regenerate itself after certain types of damage. As much as 25% of the liver can be removed, and it will still regenerate back to its original shape and size. However, the liver cannot regenerate after severe damage caused by alcohol.

Did you know?

About 600,000 particles of skin are shed every hour by each human. If you live to age 70 years, you have shed 105 pounds of dead skin.

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library